Anmelden Kostenlos registrieren

Acelrx Pharmaceuticals Inc RPE

Was ist das RPE von Acelrx Pharmaceuticals Inc?

RPE von Acelrx Pharmaceuticals Inc ist $13.522k

Was ist die Definition von RPE?

Umsatz pro Mitarbeiter (RPE) ist der Umsatz geteilt durch die Anzahl der Mitarbeiter einer Organisation.

RPE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acelrx Pharmaceuticals Inc

Was macht Acelrx Pharmaceuticals Inc?

acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v

Unternehmen mit rpe ähnlich Acelrx Pharmaceuticals Inc